Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AstraZeneca PLC (AZN)

40.92   0.94 (2.35%) 02-15 16:00
Open: 40.29 Pre. Close: 39.98
High: 41.01 Low: 40.21
Volume: 6,410,192 Market Cap: 114133M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.063 - 41.229 41.229 - 41.387
Low: 39.796 - 39.981 39.981 - 40.157
Close: 40.624 - 40.914 40.914 - 41.19

Technical analysis

as of: 2019-02-15 4:36:27 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 47.89     One year: 55.94
Support: Support1: 37.48    Support2: 35.30
Resistance: Resistance1: 41.01    Resistance2: 47.89
Pivot: 37.08
Moving Average: MA(5): 38.27     MA(20): 36.86
MA(100): 38.41     MA(250): 37.14
MACD: MACD(12,26): 0.41     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 86.23     %D(3): 82.45
RSI: RSI(14): 72.47
52-week: High: 41.78  Low: 32.69  Change(%): 20.6
Average Vol(K): 3-Month: 495082  10-Days: 454633

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AZN has closed above the upper band by 17.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 78.7% wider than normal. The large width of the bands suggest high volatility as compared to AZN's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

FDA creates new accelerated review pathway for generic drug applications

Dow Looks To Reignite Winning Streak (Wall Street Breakfast Podcast)

Wall Street Breakfast: Dow Looks To Reignite Winning Streak

AstraZeneca Group plc (AZN) CEO Pascal Soriot on Q4 2018 Results - Earnings Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2534.20
Shares Float (M) 2534.20
% Held by Insiders
% Held by Institutions 24.10
Shares Short (K) 12307
Shares Short P. Month (K)

Stock Financials

EPS 3.180
EPS Est. Current Year 1.910
EPS Est. Next Year 1.700
EPS Est. Next Quarter 0.450
Forward EPS 1.860
Book Value (p.s.) 7.800
PEG Ratio 1.67
Profit Margin 6.64
Operating Margin 6.01
Return on Assets (ttm) 3.9
Return on Equity (ttm) 19.0
Qtrly Rev. Growth -14.3
Gross Profit (p.s.) 1.796
Sales Per Share
EBITDA (p.s.) 0.722
Qtrly Earnings Growth -37.20
Operating Cash Flow (M) 1390.00
Levered Free Cash Flow (M) 2140.00

Stock Valuations

P/E 12.87
P/E Growth Ratio 0.02
P/BV 5.25
P/S 6135584256.00
P/CF 74.60

Dividends & Splits

Dividend 2.432
Dividend Yield 0.06
Dividend Pay Date 2018-09-10
Ex-Dividend Date 2018-08-09
Forward Dividend 1.400
Last Split Date 2015-07-27
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.